HomeCBI • TLV
add
Clal Biotechnology Industries Ltd.
Previous close
ILA 31.90
Day range
ILA 31.10 - ILA 31.90
Year range
ILA 28.20 - ILA 44.00
Market cap
50.03M ILS
Avg Volume
209.35K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.24M | -30.86% |
Net income | -5.18M | 74.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.18M | 30.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.61M | -83.15% |
Total assets | 52.12M | -51.43% |
Total liabilities | 19.52M | -19.93% |
Total equity | 32.60M | — |
Shares outstanding | 156.85M | — |
Price to book | 2.13 | — |
Return on assets | -5.96% | — |
Return on capital | -6.05% | — |
Cash Flow
Net change in cash
| (ILS) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.18M | 74.92% |
Cash from operations | -1.06M | 33.28% |
Cash from investing | 605.50K | -92.68% |
Cash from financing | -735.00K | 88.32% |
Net change in cash | -1.17M | -332.51% |
Free cash flow | -778.50K | 63.25% |
About
Founded
1998
Website
Employees
3